BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20161030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20170629T093000
DTEND;TZID=Europe/London:20170629T163000
DTSTAMP:20260417T065410
CREATED:20171016T090611Z
LAST-MODIFIED:20171016T090611Z
UID:17685-1498728600-1498753800@staging.medilinkmidlands.com
SUMMARY:MPD Impact and Assessment of the NEW European In Vitro Diagnostic Regulations
DESCRIPTION:For the in-vitro diagnostic sector these new regulations  will bring about major shifts in areas such as classifaction\, performance evaluation and clinical evidence. The new regulations will be fully applicable in 5 short years. Will your devices be ready?\n\nSome key elements of the new regulations include: \n  \n\nTighter pre-market controls on high risk devices and a more stringent approach to the conducting of clinical evaluations and clinical trials\nAn introduction of a risk based classification system which will apply to all in vitro diagnostic medical devices\nThis course will cover all of these key elements\, plus more. You will learn about key timelines that you need to be working to and what steps need to be taken next.\n\nMedilinkWM\, in conjunction with Acclaim Biomedical Consulting\, is offering a one day workshop exploring the new European Regulations for In Vitro Diagnostics. With over 20 years experience in Medical Devices\, Acclaim Biomedical Consulting are best placed to support and advise on the regulatory changes and the impact these will have on existing practice. \nKey Topics: \n  \n\nRisk based product classification\nConformity assessment\nClinical Evaluation\nObligations of economic operators\n\n\nLearning Objectives \nThis course aims to provide delegates with the insight and tools required to plan and implement an organisational strategy for continued access to the European Markets. The course will review critical elements of the new regulations in great depth and will run as a full day\, interactive course. \nFrom this workshop you will take away our specially made checklist\, that will assist you with making sure that your organisation is working in line with the new Regulations \n\nWho should attend? \nThe course is designed for business leaders with a good working knowledge of the current regulatory requirements \nDelegate Fees \nMember fee: £140\nNon Member fee: £190 \nRegister before Friday 2 June to receive 10% early bird discount \nFor more information or to register your place\, please contact Vanessa Bailey by emailor by calling 0121 452 5630.
URL:https://staging.medilinkmidlands.com/event/mpd-impact-and-assessment-of-the-new-european-in-vitro-diagnostic-regulations/
LOCATION:Millenium Point\, Curzon Street\, Birmingham\, B4 7XG\, United Kingdom
END:VEVENT
END:VCALENDAR